A multiple-antibiotic resistance-independent active chloramphenicol efflux in an Escherichia coli clinical isolate

Drugs Exp Clin Res. 2002;28(2-3):99-104.

Abstract

The clinical isolate, Escherichia coli 1941, exhibits high resistance to chloramphenicol and tetracycline (minimum inhibitory concentrations of 512 micrograms/ml). Neither resistance is linked to the large conjugative plasmid present in the strain. The intracellular accumulation of radiolabeled chloramphenicol increased about 9-fold after the addition of the energy uncoupler carbonyl cyanide m-chlorophenol-hydrazone to an E. coli 1941 culture, indicating the presence of an active efflux mechanism. Sequence analysis and expression study suggested that the multiple-antibiotic resistance marRAB locus and the AcrAB drug-efflux pump were not involved in this active efflux of chloramphenicol.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / metabolism*
  • Carrier Proteins*
  • Chloramphenicol / metabolism*
  • Chloramphenicol Resistance / physiology*
  • DNA Primers
  • DNA, Bacterial / genetics
  • DNA-Binding Proteins / genetics
  • Escherichia coli / genetics
  • Escherichia coli / metabolism*
  • Escherichia coli Infections / microbiology*
  • Escherichia coli Proteins / genetics
  • Lipoproteins / genetics
  • Membrane Proteins / genetics
  • Membrane Transport Proteins
  • Microbial Sensitivity Tests
  • Multidrug Resistance-Associated Proteins
  • Plasmids / genetics
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • AcrA protein, E coli
  • AcrB protein, E coli
  • Anti-Bacterial Agents
  • Carrier Proteins
  • DNA Primers
  • DNA, Bacterial
  • DNA-Binding Proteins
  • Escherichia coli Proteins
  • Lipoproteins
  • MarA protein, E coli
  • Membrane Proteins
  • Membrane Transport Proteins
  • Multidrug Resistance-Associated Proteins
  • Chloramphenicol